Learn more

UTAH INHA DDS & ADVANCED THERAPEUTICS RES CT

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    166,073
About

UTAH INHA DDS & ADVANCED THERAPEUTICS RES CT has a total of 27 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, medical technology and textiles and paper are STICHTING BIOMATERIALS SCIENCE, SHANGHAI HAOHAI BIOLOGICAL TECH CO LTD and ALLERGAN IND S A S.

Patent filings in countries

World map showing UTAH INHA DDS & ADVANCED THERAPEUTICS RES CTs patent filings in countries

Patent filings per year

Chart showing UTAH INHA DDS & ADVANCED THERAPEUTICS RES CTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lee Don Haeng 26
#2 Yang Su Geun 12
#3 Kim Se Yoon 9
#4 Lee Eun Hye 8
#5 Kim Keun Su 7
#6 Park Young Hwan 7
#7 Seo Yong Dai 4
#8 Yang Su-Geun 4
#9 Li Yixian 4
#10 Kim Min A 3

Latest patents

Publication Filing date Title
KR20160110893A Stents Coated with Functional Materials in Cell Space
WO2015088275A1 Biodegradable medical adhesive or sealant composition
KR20150069992A Biodegradable medical adhesive or sealant compositions
KR20150131435A Compositions for TACE comprising the first and second biodegradable microbeads and Methods for preparing thereof
KR20140095438A Biodegradable microbeads comprising dextran methacrylate and biocompatible anionic polymer and Methods for preparing thereof
KR20150086898A Micro particles administered in vivo through an endoscopic catheter
KR20140066099A Biodegradable microbeads with an improved ability to absorb antitumor agent comprising albumin and dextran sulfate and methods for preparing thereof
KR101441539B1 Adhesive compositions having improved hygroscopicity and preparation methods thereof
KR20140093296A Compositions for Skin Whitening Comprising LXR Agonist as Active Ingredient
KR20130025851A Tablet quickly disintegrating containg megestrol and method for producing the same
KR20140006291A Preparations for oral administration with enhanced bioavailability of megestrol acetate and method for enhancing bioavailability of oral megestrol acetate preparations
KR20130014715A Oral formulation comprising megestrol acetate powder with enhanced bioavailability, and method for preparing the same
KR20130013206A Non-vascular drug-eluting stent membrane using electrospinning, and method for preparing the same
KR20120089878A Oral pharmaceutical composition containing megestrol acetate